Home | Log in or Sign Up for full access | Tracked Organizations | Recent Tracked Activities

Recent Activities

Activities between Nov. 15, 2024, 7:17 p.m. and Nov. 22, 2024, 7:17 p.m. from: Digital Health Technology.

Click on a document link to see the original source document. Click on the name of an organization to see more organization linkages and timelines.


Aptar Digital Health Partners with the University of Geneva to Advance Migraine Research

Document Date: Nov. 21, 2024, 1:30 p.m. / Source: Business Wire
Activity Class: PartnershipActivity / Region: Switzerland
Partnership: Document Extract: Aptar Digital Health Partners with the University of Geneva to Advance Migraine Research. Aptar Digital Health, a global leader in digital health solutions, connected devices, data and study services, today announced a collaboration with the Quality of Life (QoL) technologies lab, University of Geneva, Switzerland, to advance migraine scientific research. This innovative study aims to deepen the overall understanding of migraine and help improve the lives of those affected by the condition. Its primary objective is to investigate the potential relationship between daily life digital biomarkers and migraine, focusing on how lifestyle factors may influence migraine occurrences and severity. The migraine-related data will be collected through Aptar Digital Health's mobile application Migraine Buddy®, one of the largest online communities empowering individuals that suffer from migraines.
Document Source: https://www.businesswire.com/news/home/20241121530372/en/Aptar-Digital-Health-Partners-with-the-University-of-Geneva-to-Advance-Migraine-Research (archive.org page / archive.org listing)


Aptar Digital Health Partners with the University of Geneva to Advance Migraine Research

Document Date: Nov. 21, 2024, 1:30 p.m. / Source: Business Wire
Activity Class: PartnershipActivity / Region: Switzerland
Partnership: Document Extract: Aptar Digital Health, a global leader in digital health solutions, connected devices, data and study services, today announced a collaboration with the Quality of Life (QoL) technologies lab, University of Geneva, Switzerland, to advance migraine scientific research. This innovative study aims to deepen the overall understanding of migraine and help improve the lives of those affected by the condition. Its primary objective is to investigate the potential relationship between daily life digital biomarkers and migraine, focusing on how lifestyle factors may influence migraine occurrences and severity. The migraine-related data will be collected through Aptar Digital Health's mobile application Migraine Buddy®, one of the largest online communities empowering individuals that suffer from migraines. Migraine is a complex neurological disorder characterized by recurrent episodes of disabling headaches and associated symptoms.
Document Source: https://www.businesswire.com/news/home/20241121530372/en/Aptar-Digital-Health-Partners-with-the-University-of-Geneva-to-Advance-Migraine-Research (archive.org page / archive.org listing)


Aptar Digital Health Partners with the University of Geneva to Advance Migraine Research

Document Date: Nov. 21, 2024, 1:30 p.m. / Source: Business Wire
Activity Class: PartnershipActivity / Region: Switzerland
Partnership: Document Extract: While the underlying biological mechanisms of migraine are not fully understood, there is evidence that repetitive daily life behaviors can play a role in triggering attacks and influencing their severity2. Participants will be recruited for the one-year study, during which they will monitor vital parameters such as heart rate, sleep patterns and daily activities, including walking and sports. Participants will also be asked to complete quality-of-life and migraine specific surveys every three months to track their overall condition. " We are delighted to partner with the University of Geneva on this migraine research study. This collaboration embodies our vision of integrating innovative digital health solutions to better understand and manage chronic conditions like migraine ," stated Alexandre Urani, Head of Clinical Product Development at Aptar Digital Health. ``
Document Source: https://www.businesswire.com/news/home/20241121530372/en/Aptar-Digital-Health-Partners-with-the-University-of-Geneva-to-Advance-Migraine-Research (archive.org page / archive.org listing)


VSee Health, Health Tech Without Borders, and iDocta Expand Clinton Global Initiative Telehealth Pilots in Conflict-affected Regions of Africa

Document Date: Nov. 19, 2024, 1 p.m. / Source: Business Wire
Activity Class: PartnershipActivity
Partnership: Document Extract: Mary Showstark, HTWB Chief Liaison Officer stated, "We feel fortunate to have partnered with VSee Health on multiple humanitarian projects. Its telehealth platform has proven to be reliable, adaptable, and quick to set up, especially for life and death situations. It makes it possible for us to do what we do: provide immediate access to care in disasters and emergencies ." " We are excited with the progress we have made with Project VITAL ," said Yap Boum, iDocta founder. " We look forward to this next phase of our work in Cameroon, building sustainability with local expertise and expanding telemedicine services to more locations that are in desperate need of healthcare access ."
Document Source: https://www.businesswire.com/news/home/20241119548026/en/VSee-Health-Health-Tech-Without-Borders-and-iDocta-Expand-Clinton-Global-Initiative-Telehealth-Pilots-in-Conflict-affected-Regions-of-Africa (archive.org page / archive.org listing)


VSee Health, Health Tech Without Borders, and iDocta Expand Clinton Global Initiative Telehealth Pilots in Conflict-affected Regions of Africa

Document Date: Nov. 19, 2024, 1 p.m. / Source: Business Wire
Activity Class: PartnershipActivity / Region: Africa, Republic of Cameroon
Partnership: Document Extract: VSee Health, Inc. (Nasdaq: VSEE) , a provider of comprehensive digital health services for the rapid and scalable development of secure, customized telehealth workflow streams; Health Tech Without Borders (HTWB) a global non-profit providing digital health interventions in humanitarian crises; and iDocta, a medical digitization company, are expanding the Project VITAL Africa telehealth pilots - a commitment made at the Clinton Global Initiative 2023 Annual Meeting in September 2023 - to strengthen health systems and promote equitable health in Cameroon through sustainable training, telehealth, and innovative technology. Dr. Milton Chen, Co-CEO of VSee Health said, "VSee Health from its beginning has been focused on designing secure, robust, and scalable technology that impacts our society. The successful use of our customizable platform to provide healthcare access in war-torn and remote parts of Africa demonstrates exactly what our technology was built to do. We 're proud to take part in this Clinton Global Initiative commitment and to support HTWB and iDocta in a meaningful way ." Mary Showstark, HTWB Chief Liaison Officer stated, "We feel fortunate to have partnered with VSee Health on multiple humanitarian projects.
Document Source: https://www.businesswire.com/news/home/20241119548026/en/VSee-Health-Health-Tech-Without-Borders-and-iDocta-Expand-Clinton-Global-Initiative-Telehealth-Pilots-in-Conflict-affected-Regions-of-Africa (archive.org page / archive.org listing)


Health2Sync Partners with Singapore Health Promotion Board and Abbott to Launch Innovative DigiCoach Program Tackling Pre-diabetes and Obesity

Document Date: Nov. 19, 2024, 1 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity / Region: Republic of Singapore
Partnership: Document Extract: Participants can use a continuous glucose monitoring (CGM) device and the Health2Sync mobile app to track their food intake and physical activity, learning how dietary and exercise choices impact glucose levels. This demonstrates Health2Sync's ongoing effort in public-private collaboration to battle chronic diseases in the region. TAIPEI, Nov. 19, 2024 /PRNewswire/ - Health2Sync, a leading digital health company, announced today that it has partnered with the Health Promotion Board (HPB) of Singapore and Abbott on "DigiCoach ," a fully automated engagement program leveraging Continuous Glucose Monitors (CGM) and its data. The program aims to empower individuals with pre-diabetes or high Body Mass Index (BMI) to take control of their health and prevent or delay the onset of diabetes through the use of technology and personalized coaching. The DigiCoach program, powered by Abbott's continuous glucose monitor (CGM) technology, provides real-time insights into glucose levels in the Health2Sync mobile application.
Document Source: https://www.prnewswire.com/news-releases/health2sync-partners-with-singapore-health-promotion-board-and-abbott-to-launch-innovative-digicoach-program-tackling-pre-diabetes-and-obesity-302308327.html (archive.org page / archive.org listing)


Health2Sync Partners with Singapore Health Promotion Board and Abbott to Launch Innovative DigiCoach Program Tackling Pre-diabetes and Obesity

Document Date: Nov. 19, 2024, 1 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity / Region: Republic of Singapore
Partnership: Document Extract: Health2Sync Partners with Singapore Health Promotion Board and Abbott to Launch Innovative DigiCoach Program Tackling Pre-diabetes and Obesity. " DigiCoach program" is a pilot program by Singapore Health Promotion Board, Health2Sync, and Abbott that aims to help individuals with pre-diabetes or high BMI prevent or delay the onset of diabetes. Participants can use a continuous glucose monitoring (CGM) device and the Health2Sync mobile app to track their food intake and physical activity, learning how dietary and exercise choices impact glucose levels. This demonstrates Health2Sync's ongoing effort in public-private collaboration to battle chronic diseases in the region. TAIPEI, Nov. 19, 2024 /PRNewswire/ - Health2Sync, a leading digital health company, announced today that it has partnered with the Health Promotion Board (HPB) of Singapore and Abbott on "DigiCoach ," a fully automated engagement program leveraging Continuous Glucose Monitors (CGM) and its data.
Document Source: https://www.prnewswire.com/news-releases/health2sync-partners-with-singapore-health-promotion-board-and-abbott-to-launch-innovative-digicoach-program-tackling-pre-diabetes-and-obesity-302308327.html (archive.org page / archive.org listing)


Health2Sync Partners with Singapore Health Promotion Board and Abbott to Launch Innovative DigiCoach Program Tackling Pre-diabetes and Obesity

Document Date: Nov. 19, 2024, 1 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity / Region: Republic of Singapore
Partnership: Document Extract: By analyzing these data, the program delivers personalized feedback and health coaching content, including prompts and questions, encouraging self-reflection on successful strategies for blood glucose management and identifying further steps for lifestyle improvement. " HPB is constantly pursuing innovations that enable Singaporeans to better manage their own health. Our collaboration with Abbott and Health2Sync will allow us to trial new solutions that deliver more timely and actionable recommendations to Singaporeans, enabling them to self-help in preventing or managing the onset of diabetes. These solutions can be potentially scaled up in future to help more Singaporeans ," said Tay Choon Hong, Chief Executive Officer, HPB. " We are excited to collaborate with HPB and Abbott to launch the DigiCoach program ," said Ed Deng, co-founder and CEO at Health2Sync.
Document Source: https://www.prnewswire.com/news-releases/health2sync-partners-with-singapore-health-promotion-board-and-abbott-to-launch-innovative-digicoach-program-tackling-pre-diabetes-and-obesity-302308327.html (archive.org page / archive.org listing)


StoryCatch Partners Acquires EmpiraMed

Document Date: Nov. 20, 2024, 1:43 p.m. / Source: GlobeNewswire
Activity Class: CorporateFinanceActivity / Type: Acquisition / Region: Maynard
Buyer: Target: Document Extract: WELLESLEY HILLS, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) - StoryCatch Partners, a Public Benefit Corporation leveraging the power of individual stories to improve mental and physical wellbeing, today announced that it has acquired Maynard, Mass. - based EmpiraMed Inc., a digital health technology leader in the field of virtual clinical studies for real-world evidence.
Document Source: https://www.globenewswire.com/news-release/2024/11/20/2984449/0/en/StoryCatch-Partners-Acquires-EmpiraMed.html (archive.org page / archive.org listing)


Smart ring maker Oura hits a $5bn valuation after raising $75m

Document Date: Nov. 19, 2024, 12:45 p.m. / Source: Sifted
Activity Class: CorporateFinanceActivity / Type: Investment / Region: Japan
Investor: Target: Document Extract: Smart ring maker Oura has hit a $ 5.2bn valuation after raising a $ 75m Series D from US continuous glucose monitoring (CGM) giant Dexcom.
Document Source: https://sifted.eu/articles/smart-ring-maker-oura-raises-75m-news (archive.org page / archive.org listing)


Smart ring maker Oura hits a $5bn valuation after raising $75m

Document Date: Nov. 19, 2024, 12:45 p.m. / Source: Sifted
Activity Class: CorporateFinanceActivity / Type: Ipo / Region: Japan
Vendor: Document Extract: Smart ring maker Oura hits a $ 5bn valuation after raising $ 75m.
Document Source: https://sifted.eu/articles/smart-ring-maker-oura-raises-75m-news (archive.org page / archive.org listing)


Jimini Health Launches with $8M in Funding to Transform Mental Health with Responsible AI-Supported Therapy

Document Date: Nov. 19, 2024, 1 p.m. / Source: GlobeNewswire
Activity Class: CorporateFinanceActivity / Type: Investment / Region: New York City
Investor: Target: Document Extract: NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) - Jimini Health, a digital health company setting a new standard in mental healthcare with its unique, clinician - led therapy model augmented by responsible AI, today announced its launch with $ 8 million in pre-seed funding, including from Zetta Venture Partners, LionBird, PsyMed, BoxGroup, Arkitekt Ventures, SCB, and others.
Document Source: https://www.globenewswire.com/news-release/2024/11/19/2983540/0/en/Jimini-Health-Launches-with-8M-in-Funding-to-Transform-Mental-Health-with-Responsible-AI-Supported-Therapy.html (archive.org page / archive.org listing)


Trawick International Enhances Global Medical Coverage with Access to Cleveland Clinic World-Renowned Care

Document Date: Nov. 21, 2024, noon / Source: GlobeNewswire
Activity Class: PartnershipActivity
Partnership: Document Extract: Trawick International Enhances Global Medical Coverage with Access to Cleveland Clinic World-Renowned Care. MIAMI, Nov. 21, 2024 (GLOBE NEWSWIRE) - Trawick International, a leading global insurance provider, announces that they are working together with Cleveland Clinic, a world-renowned healthcare institution recognized for its excellence in medical specialties such as cardiology and cardiovascular surgery. Policyholders of Trawick International's Plan VIVA, as well as customers of GlobalMex and Trawick International's United Kingdom and European international private medical insurance plans, now have access to Cleveland Clinic's Global Patient Services program. Insured members will enjoy the benefits of coordinated care tailored to their unique needs, including assistance with appointment scheduling, interpretation services, and guidance throughout their treatment journey. Cleveland Clinic's Global Patient Services team is dedicated to ensuring a seamless experience for international patients before, during, and after their visit.
Document Source: https://www.globenewswire.com/news-release/2024/11/21/2985081/0/en/Trawick-International-Enhances-Global-Medical-Coverage-with-Access-to-Cleveland-Clinic-World-Renowned-Care.html (archive.org page / archive.org listing)


Novartis, Ratio sign radiopharmaceutical pact to the tune of $745M biobucks

Document Date: Nov. 18, 2024, 1 p.m. / Source: Fierce Biotech
Activity Class: PartnershipActivity / Region: Boston
Partnership: Document Extract: Novartis, Ratio sign radiopharmaceutical pact to the tune of $ 745M biobucks. Novartis is adding another radiopharmaceutical program to its collection, penning a deal worth $ 745 million in biobucks for rights to a cancer candidate from Ratio Therapeutics. Boston - based biotech Ratio and Novartis will work together researching and selecting a somatostatin receptor 2 (SSTR2) -targeting development candidate, according to a Nov. 18 release. From there, Novartis will take on the rest of the responsibilities around the asset, including further development and potential commercialization activities. The worldwide licensing agreement will leverage Ratio's radioligand tech platforms, which are designed to develop fit-for-purpose radiopharmaceuticals for therapy and imaging.
Document Source: https://www.fiercebiotech.com/biotech/novartis-ratio-sign-radiopharmaceutical-pact-tune-745m-biobucks (archive.org page / archive.org listing)


H.I.G. Growth Completes Significant Growth Investment in Carebox

Document Date: Nov. 18, 2024, 2:30 p.m. / Source: PR Newswire
Activity Class: CorporateFinanceActivity / Type: Investment / Region: United States
Investor: Participant: Target: Document Extract: SAN FRANCISCO, Nov. 18, 2024 /PRNewswire/ - H.I.G.
Document Source: https://www.prnewswire.com/news-releases/hig-growth-completes-significant-growth-investment-in-carebox-302307834.html (archive.org page / archive.org listing)


Biofourmis Supports Expansion of Remote Patient Monitoring and Introduction of Home Based Hospital Care at Lee Health

Document Date: Nov. 18, 2024, 1 p.m. / Source: Business Wire
Activity Class: PartnershipActivity
Partnership: Document Extract: Biofourmis, a leading global technology-enabled care delivery company, and Lee Health, a not-for-profit health system comprised of five hospitals across Southwest Florida, are preparing to launch Hospital at Home, a home based hospital care model and expand their remote patient monitoring (RPM) program to support patients across the continuum. Lee Health is a leader in the remote patient monitoring space, touting a 50 % reduction in 30-day readmissions while also being one of the largest RPM programs in the country carrying an average daily census of more than 700 patients. As part of the agreement, Biofourmis will support Lee Health's entire RPM service line while also launching a new Hospital at Home program that will be the first of its kind in Southwest Florida. Hospital at Home is an alternative inpatient site of care whereby patients can receive hospital level care in the comfort of their own home. Bringing all of the resources, supplies, and care team to the patient's home has demonstrated improved patient satisfaction and clinical outcomes.
Document Source: https://www.businesswire.com/news/home/20241118565728/en/Biofourmis-Supports-Expansion-of-Remote-Patient-Monitoring-and-Introduction-of-Home-Based-Hospital-Care-at-Lee-Health (archive.org page / archive.org listing)


Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions

Document Date: Nov. 18, 2024, 11 a.m. / Source: Business Wire
Activity Class: RoleActivity / Type: Starting
Role: Person: Organization: Document Extract: Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) , the leading health and wellness platform, today announced Deb Autor, former deputy commissioner at the FDA, will join the company's board of directors, and Janet Stevens, a pharmaceutical quality expert, will join the company as Global Head of Quality & Safety.
Document Source: https://www.businesswire.com/news/home/20241118954274/en/Hims-Hers-Appoints-Tenured-Pharmaceutical-Regulatory-and-Quality-Experts-to-Key-Leadership-Positions (archive.org page / archive.org listing)


Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions

Document Date: Nov. 18, 2024, 11 a.m. / Source: Business Wire
Activity Class: RoleActivity / Type: Starting
Role: Person: Organization: Document Extract: Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) , the leading health and wellness platform, today announced Deb Autor, former deputy commissioner at the FDA, will join the company's board of directors, and Janet Stevens, a pharmaceutical quality expert, will join the company as Global Head of Quality & Safety.
Document Source: https://www.businesswire.com/news/home/20241118954274/en/Hims-Hers-Appoints-Tenured-Pharmaceutical-Regulatory-and-Quality-Experts-to-Key-Leadership-Positions (archive.org page / archive.org listing)


Eagle Telemedicine Appoints Chris Penwarden as New Vice President of Sales

Document Date: Nov. 21, 2024, 2 p.m. / Source: prweb
Activity Class: RoleActivity / Type: Starting
Role: Person: Organization: Document Extract: Eagle Telemedicine Appoints Chris Penwarden as New Vice President of Sales.
Document Source: https://www.prweb.com/releases/eagle-telemedicine-appoints-chris-penwarden-as-new-vice-president-of-sales-302312778.html (archive.org page / archive.org listing)

Archive.org page links will work if the page has already been archived by archive.org, but we can't guarantee which pages archive.org has archived so far.

Treat sameAsNameOnly relationship as same? Yes (Turn Off)

Site Stats | About (includes privacy and cookie notices)
(c) by 1145, 2023-2024. Data licensed under the Open Database License. Please send an email if you need a non-share-alike license and/or you need API access.